Correlation Between Cue Biopharma and Haleon Plc

Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Haleon Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Haleon Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cue Biopharma and Haleon plc, you can compare the effects of market volatilities on Cue Biopharma and Haleon Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Haleon Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Haleon Plc.

Diversification Opportunities for Cue Biopharma and Haleon Plc

-0.76

Correlation Coefficient

Cue Biopharma  Haleon Plc

Pay attention - limited upside

The 3 months correlation between Cue and Haleon is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Haleon plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haleon plc and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Haleon Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haleon plc has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Haleon Plc go up and down completely randomly.

Pair Corralation between Cue Biopharma and Haleon Plc

Considering the 90-day investment horizon Cue Biopharma is expected to generate 12.46 times more return on investment than Haleon Plc. However, Cue Biopharma is 12.46 times more volatile than Haleon plc. It trades about 0.13 of its potential returns per unit of risk. Haleon plc is currently generating about -0.08 per unit of risk. If you would invest  66.00  in Cue Biopharma on September 3, 2024 and sell it today you would earn a total of  56.00  from holding Cue Biopharma or generate 84.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cue Biopharma  vs.  Haleon plc

Cue Biopharma

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Haleon plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Haleon plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Haleon Plc is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Cue Biopharma and Haleon Plc

The main advantage of trading using opposite Cue Biopharma and Haleon Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Haleon Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haleon Plc will offset losses from the drop in Haleon Plc's long position.

The idea behind Cue Biopharma and Haleon plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.